TORONTO, ON / ACCESSWIRE / June 8, 2017 / Hamilton Thorne Ltd. (TSX-V: HTL.V, OTC PINK: HTLZF) will be presenting at this year's
MicroCap Conference on June 27th in Toronto.
CONFERENCE OVERVIEW AND STRUCTURE
The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to
be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and
mingle with other microcap investors.
The MicroCap Conference will take place in Toronto at the Sheraton Centre Hotel on June 27th. Registration will begin on Tuesday
at 7:00AM, and the event will last until the evening. The day will be jam-packed with company sessions, presentations, good food,
and plenty of time to network with other investors over drinks at the reception. This event does not allow service providers - only
portfolio managers, analysts, and private investors.
REGISTRATION FOR INVESTORS
To register, please go to our website (http://microcapconf.com/conferences/toronto-2017/), and click "Request Registration"
News Compliments of ACCESSWIRE
About Hamilton Thorne Ltd. (www.hamiltonthorne.com)
Hamilton Thorne is a leading world-wide provider of precision instruments, consumables, software and services that reduce cost,
increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental
biology research markets. Hamilton Thorne's laser products attach to standard inverted microscopes and operate as micro-surgical
devices, enabling a wide array of scientific applications and In Vitro Fertilization (IVF) procedures. Its image analysis systems
are designed to bring quality, efficiency and reliability to studies of reproductive cells in the human fertility, animal sciences
and reproductive toxicology fields. Hamilton Thorne's standardized toxicology assays and quality control testing services help to
improve outcomes in human IVF clinics. Hamilton Thorne's growing worldwide customer base consists of pharmaceutical companies,
biotechnology companies, fertility clinics, university research centers, animal breeding companies, and other commercial and
academic research establishments, including Harvard, MIT, Yale, McGill, Oxford, Cambridge, the Smithsonian Institution, Charles
River Labs, Covance, ABS Global, Sexing Technologies, Merck, Cook Medical, Novartis, Pfizer, and Dow Chemical.
Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the
exchange), accepts responsibility for the adequacy or accuracy of this release.
FOR MORE INFORMATION
Please visit: www.microcapconf.com
Or, contact Tony Yu at tony@microcapconf.com
SOURCE: Hamilton Thorne Ltd.
